Production of structured designer particles with high encapsulation capacities and efficiencies. This project aims to develop a superior encapsulation technology that is capable of producing particles with precisely controlled physical and chemical properties. The technology has application in a wide range of industries requiring packaging active ingredients into particle form to achieve desirable end-use performances. It has an economic impact of multibillion dollars per annum. In particular, i ....Production of structured designer particles with high encapsulation capacities and efficiencies. This project aims to develop a superior encapsulation technology that is capable of producing particles with precisely controlled physical and chemical properties. The technology has application in a wide range of industries requiring packaging active ingredients into particle form to achieve desirable end-use performances. It has an economic impact of multibillion dollars per annum. In particular, it will facilitate the release of new drugs to the market for the pharmaceutical industry, and increase the range and improve the availability of quality foods for the food industry. This will bring about a healthier life style to the Australian population.Read moreRead less
Discrete Element Method for Analysis and Design of Pharmaceutical Encapsulation. Tablets represent the preferred method of dose delivery in the pharmaceutical industry, with over 80% of the market. PressFit - gelcaps have recently been developed, which encase a tablet core within a gelatin coating. The product combines the consumer appeal of capsules with the processing convenience of tablets, and provides a high degree of tamper-resistance. An important issue is that the caplets are required ....Discrete Element Method for Analysis and Design of Pharmaceutical Encapsulation. Tablets represent the preferred method of dose delivery in the pharmaceutical industry, with over 80% of the market. PressFit - gelcaps have recently been developed, which encase a tablet core within a gelatin coating. The product combines the consumer appeal of capsules with the processing convenience of tablets, and provides a high degree of tamper-resistance. An important issue is that the caplets are required to have very precise dimensional precision, an issue not previously of high priority for tabletting . This project seeks to enhance the competitive advantage of this new technology, through a combination of advanced mathematical modeling supported by experiments.Read moreRead less
Controlled Crystallisation of Bioactives. The new technologies developed in this project for bioactive recovery and particle design will allow the development of new value added products for Australia's growing biotechnology industry, especially in pharmaceuticals, neutraceuticals and functional foods. Two PhD students will receive excellent research training to then move into research and development in these industries.
Particle Design for Recovery and Delivery of Bioactives. This project will develop new strategies for economically viable recovery of bioactives from complex solutions, slurries and sludges of biomaterials eg. waste streams from milk and soy bean processing, and fermentation broths. These bioactives, often proteins, have growing applications as high value drugs, nutriceuticals and food additives but are difficult to separate and to maintain in an active form. Crystallisation will be used as a ....Particle Design for Recovery and Delivery of Bioactives. This project will develop new strategies for economically viable recovery of bioactives from complex solutions, slurries and sludges of biomaterials eg. waste streams from milk and soy bean processing, and fermentation broths. These bioactives, often proteins, have growing applications as high value drugs, nutriceuticals and food additives but are difficult to separate and to maintain in an active form. Crystallisation will be used as a primary separation technique. Molecular studies of protein interactions will be used to predict good crystallisation conditions and linked to process crystallisation studies. Both standard and novel particle design strategies will be used to control crystal size and morphology, as well as package the boactive in a deliverable form without loss of activity.Read moreRead less
Jet breakup of emulsions for the production of designer microparticulate drug delivery systems. Drug delivery systems are an important and growing part of the pharmaceutical and biotechnology market. The growth is estimated to be at 23% p.a. and is tied to the requirements for more precise and complex delivery profiles by highly potent drugs or vaccines (bioactives). To achieve the required level of control and precision, improved encapsulation technologies are needed to produce particles of a p ....Jet breakup of emulsions for the production of designer microparticulate drug delivery systems. Drug delivery systems are an important and growing part of the pharmaceutical and biotechnology market. The growth is estimated to be at 23% p.a. and is tied to the requirements for more precise and complex delivery profiles by highly potent drugs or vaccines (bioactives). To achieve the required level of control and precision, improved encapsulation technologies are needed to produce particles of a precise size and narrow size distribution. This project aims to develop an innovative technology for the production of superior uniformly sized particulate drug delivery systems for the delivery of the "next generation" bioactives.Read moreRead less
Particle design and recovery of bioactives by crystallisation and precipitation. This project will develop new strategies for economically viable recovery of bioactives from complex solutions of biomaterials eg. separation of biopharmaceuticals from genetically engineered cell culture, food ingredient processing, functional food and nutraceutical extraction from natural sources. Crystallisation and precipitation will be used as primary separation techniques. We propose a new paradigm in which ....Particle design and recovery of bioactives by crystallisation and precipitation. This project will develop new strategies for economically viable recovery of bioactives from complex solutions of biomaterials eg. separation of biopharmaceuticals from genetically engineered cell culture, food ingredient processing, functional food and nutraceutical extraction from natural sources. Crystallisation and precipitation will be used as primary separation techniques. We propose a new paradigm in which molecular studies of protein interactions will be used to predict good crystallisation conditions and linked to process crystalliation studies. Studies will use a model system of egg white protein mixtures and a real system of industrial importance - the purification of valuable protein products from soy beans (valued at $500 million per year world wide). Soy beans studies will include pilot scale tests at Dupont's industrial reseach laboratories.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0238094
Funder
Australian Research Council
Funding Amount
$197,000.00
Summary
Fine and Ultrafine Particle - Characterisation and Research Facility. The proposed grant aims to establish an integrated facility for characterising and researching fine and ultrafine particles. It will serve various research groups of three collaborating universities. Current facilities are limited to characterisation of liquid-borne particles down to 10 nm size. To extend the groups research interests into aerosols and nanoparticles the facilities requested in this grant are essential. Equipme ....Fine and Ultrafine Particle - Characterisation and Research Facility. The proposed grant aims to establish an integrated facility for characterising and researching fine and ultrafine particles. It will serve various research groups of three collaborating universities. Current facilities are limited to characterisation of liquid-borne particles down to 10 nm size. To extend the groups research interests into aerosols and nanoparticles the facilities requested in this grant are essential. Equipment critical for research into catalytic processes is also requested. Integration of the groups will create a force that institutions and industries,nation-wide, can turn to when the need for competent analytical and research solutions for particles and catalysis arises.Read moreRead less
Scale-up and Intelligent Control of Granulation Processes. Granulation is the process that forms granular products with carefully targeted properties from powdery or liquid feeds. Granular products abound in the pharmaceutical, agricultural & industrial chemicals, and food & consumer goods industries. Poor understanding of the granulation causes delays in the time to market of new products and poor efficiency in large scale continuous granulation plants. This project will build on recent adva ....Scale-up and Intelligent Control of Granulation Processes. Granulation is the process that forms granular products with carefully targeted properties from powdery or liquid feeds. Granular products abound in the pharmaceutical, agricultural & industrial chemicals, and food & consumer goods industries. Poor understanding of the granulation causes delays in the time to market of new products and poor efficiency in large scale continuous granulation plants. This project will build on recent advances in the understanding of granulation fundamentals to (1) develop new robust design and scale up rules (2) develop intelligent control schemes for continuous granulation circuits, and (3) develop a new generation of regime separated granulators. The project is receiving substantial support from 3 industry partners (MSD Australia, Incitec and WMC Fertilizers) with cash contributions over 40% of the ARC grant requested, as well as very substantial in-kind contributions.Read moreRead less